ERCC1-expressing circulating tumor cells as a potential diagnostic tool for monitoring response to platinum-based chemotherapy and for predicting post-therapeutic outcome of ovarian cancer

BACKGROUND: We recently showed that the presence of ERCC1(+)CTCs is an independent predictive biomarker for platinum-resistance and poor prognosis of ovarian cancer. The goal of our current research was to determine how the auxiliary assessment of ERCC1-transcripts influences overall CTC-detection r...

Descripción completa

Detalles Bibliográficos
Autores principales: Chebouti, Issam, Kuhlmann, Jan Dominik, Buderath, Paul, Weber, Stephan, Wimberger, Pauline, Bokeloh, Yvonne, Hauch, Siegfried, Kimmig, Rainer, Kasimir-Bauer, Sabine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5421848/
https://www.ncbi.nlm.nih.gov/pubmed/28388557
http://dx.doi.org/10.18632/oncotarget.13286

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5421848/
https://www.ncbi.nlm.nih.gov/pubmed/28388557
http://dx.doi.org/10.18632/oncotarget.13286

Ejemplares similares